1. Soh, Joanne Ec, Abu, Nadiah, Sagap, Ismail, Ab Mutalib, Nurul S, Jamal, Rahman. 2019. Validation of immunogenic PASD1 peptides against HLA-A*24:02 colorectal cancer. In Immunotherapy, 11, 1205-1219. doi:10.2217/imt-2019-0073. https://pubmed.ncbi.nlm.nih.gov/31478431/
2. Xu, Zhi-Sheng, Zhang, Hong-Xia, Zhang, Yu-Long, Wang, Yan-Yi, Shu, Hong-Bing. 2016. PASD1 promotes STAT3 activity and tumor growth by inhibiting TC45-mediated dephosphorylation of STAT3 in the nucleus. In Journal of molecular cell biology, 8, 221-31. doi:10.1093/jmcb/mjw005. https://pubmed.ncbi.nlm.nih.gov/26892021/
3. Michael, Alicia K, Harvey, Stacy L, Sammons, Patrick J, Banham, Alison H, Partch, Carrie L. 2015. Cancer/Testis Antigen PASD1 Silences the Circadian Clock. In Molecular cell, 58, 743-54. doi:10.1016/j.molcel.2015.03.031. https://pubmed.ncbi.nlm.nih.gov/25936801/
4. Yang, Yang, Qu, Yajuan, Li, Zhaopeng, Lei, Youming, Bai, Song. 2022. Identification of Novel Characteristics in TP53-Mutant Hepatocellular Carcinoma Using Bioinformatics. In Frontiers in genetics, 13, 874805. doi:10.3389/fgene.2022.874805. https://pubmed.ncbi.nlm.nih.gov/35651938/
5. Ansari, Sara, Nikpour, Parvaneh. 2023. Identification of Cancer/Testis Antigens Related to Gastric Cancer Prognosis Based on Co-Expression Network and Integrated Transcriptome Analyses. In Advanced biomedical research, 12, 52. doi:10.4103/abr.abr_400_21. https://pubmed.ncbi.nlm.nih.gov/37057240/
6. Avdonkina, N A, Danilova, A B, Misyurin, V A, Gafton, G I, Baldueva, I A. 2020. Biological features of tissue and bone sarcomas investigated using an in vitro model of clonal selection. In Pathology, research and practice, 217, 153214. doi:10.1016/j.prp.2020.153214. https://pubmed.ncbi.nlm.nih.gov/33290900/
智鼠故事 
